First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).

Détails

Ressource 1Télécharger: 10549_2016_Article_3935.pdf (448.00 [Ko])
Etat: Public
Version: Final published version
ID Serval
serval:BIB_4FF9410CCC1B
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Périodique
Breast cancer research and treatment
Auteur(s)
Rageth C.J., O'Flynn E.A., Comstock C., Kurtz C., Kubik R., Madjar H., Lepori D., Kampmann G., Mundinger A., Baege A., Decker T., Hosch S., Tausch C., Delaloye J.F., Morris E., Varga Z.
ISSN
1573-7217 (Electronic)
ISSN-L
0167-6806
Statut éditorial
Publié
Date de publication
09/2016
Peer-reviewed
Oui
Volume
159
Numéro
2
Pages
203-213
Langue
anglais
Notes
Publication types: Congresses
Publication Status: ppublish
Résumé
The purpose of this study is to obtain a consensus for the therapy of B3 lesions. The first International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions) including atypical ductal hyperplasia (ADH), flat epithelial atypia (FEA), classical lobular neoplasia (LN), papillary lesions (PL), benign phyllodes tumors (PT), and radial scars (RS) took place in January 2016 in Zurich, Switzerland organized by the International Breast Ultrasound School and the Swiss Minimally Invasive Breast Biopsy group-a subgroup of the Swiss Society of Senology. Consensus recommendations for the management and follow-up surveillance of these B3 lesions were developed and areas of research priorities were identified. The consensus recommendation for FEA, LN, PL, and RS diagnosed on core needle biopsy or vacuum-assisted biopsy (VAB) is to therapeutically excise the lesion seen on imaging by VAB and no longer by open surgery, with follow-up surveillance imaging for 5 years. The consensus recommendation for ADH and PT is, with some exceptions, therapeutic first-line open surgical excision. Minimally invasive management of selected B3 lesions with therapeutic VAB is acceptable as an alternative to first-line surgical excision.

Mots-clé
Biopsy, Large-Core Needle, Breast/pathology, Breast Neoplasms/diagnosis, Carcinoma, Intraductal, Noninfiltrating/pathology, Carcinoma, Lobular/pathology, Disease Management, Female, Humans, Image-Guided Biopsy, Mammography/methods, Phyllodes Tumor/pathology, Population Surveillance/methods, Practice Guidelines as Topic, B3 lesions, Breast, Breast surgery, Consensus, Uncertain malignant potential, Vacuum-assisted biopsy
Pubmed
Web of science
Open Access
Oui
Création de la notice
15/09/2016 20:10
Dernière modification de la notice
20/08/2019 14:05
Données d'usage